Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „weeks“
Suchtreffer
Begriffe & Kennungen
Imraldi · 4.8 · During the controlled portions of pivotal adalimumab trials in adults of at least 12 weeks in duration in pati
Eintrag öffnenIsentress · 4.8 · At 96-weeks, in treatment-experienced patients, Grade 2 or higher laboratory abnormalities that represent a wo
Eintrag öffnenIsentress · 4.8 · At 96-weeks, in treatment-experienced patients, Grade 2 or higher laboratory abnormalities that represent a wo
Eintrag öffnenIsentress · 4.8 · At 96-weeks, in treatment-experienced patients, Grade 2 or higher laboratory abnormalities that represent a wo
Eintrag öffnenIsentress · 4.8 · HIV-1 Exposed Neonates In IMPAACT P1110 (see section 5.2) eligible infants were at least 37 weeks gestation an
Eintrag öffnenIsentress · 4.8 · HIV-1 Exposed Neonates In IMPAACT P1110 (see section 5.2) eligible infants were at least 37 weeks gestation an
Eintrag öffnenIsentress · 4.8 · HIV-1 Exposed Neonates In IMPAACT P1110 (see section 5.2) eligible infants were at least 37 weeks gestation an
Eintrag öffnenIsentress · 4.8 · HIV-1 Exposed Neonates In IMPAACT P1110 (see section 5.2) eligible infants were at least 37 weeks gestation an
Eintrag öffnenIsentress · 4.8 · Infants and toddlers 4 weeks to less than 2 years of age Raltegravir has also been studied in 26 HIV-1 infecte
Eintrag öffnenIsentress · 4.8 · Infants and toddlers 4 weeks to less than 2 years of age Raltegravir has also been studied in 26 HIV-1 infecte
Eintrag öffnenIsentress · 4.8 · Infants and toddlers 4 weeks to less than 2 years of age Raltegravir has also been studied in 26 HIV-1 infecte
Eintrag öffnenIsentress · 4.8 · Infants and toddlers 4 weeks to less than 2 years of age Raltegravir twice daily has also been studied in 26 H
Eintrag öffnenItuxredi · 4.8 · Haematologic adverse reactions In clinical trials with rituximab monotherapy given for 4 weeks, haematological
Eintrag öffnenItuxredi · 4.8 · Patients received 2 x 1000 mg of rituximab separated by an interval of two weeks; in addition to methotrexate
Eintrag öffnenJakavi · 4.8 · 14 41.4 weeks (range 0.7 to 127.3 weeks). In the pool of paediatric patients ≥2 years of age (10 patients in R
Eintrag öffnenJardiance · 4.8 · In 6 placebo-controlled trials of 18 to 24 weeks duration, 3 534 patients were included of which 1 183
Eintrag öffnenJascayd · 4.8 · In clinical trials, weight decrease started after the second week of treatment and stabilised after 12 weeks o
Eintrag öffnenJascayd · 4.8 · Table 2. Frequencies of diarrhoea by background treatment subgroups over 52 weeks in the FIBRONEER-IPF trial (
Eintrag öffnenJavlor · 4.3 · Hypersensitivity to the active substance or other vinca alkaloids. Recent (within 2 weeks) or current severe i
Eintrag öffnenJyseleca · 4.8 · In placebo-controlled Phase 3 studies with background DMARDs (FINCH 1 and FINCH 2) through 12 weeks, CPK eleva
Eintrag öffnen